Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

Table of Contents

- Malignant Mesothelioma overview

- Pathophysiology

- Symptoms of disease

- Etiology of disease

- Diagnosis of disease

- Treatment of disease

- Overview of Marketed drugs

- Drug Description

- Mechanism of Action

- Pharmacokinetics Properties

- Marketed Details

- Patent Information

- Patent Exclusivity Expiry Assessment United States (US)

- Patents Details

- Historical and Forecasted sales of marketed molecules in the Global Malignant Mesothelioma Market

- Global Epidemiology of Malignant Mesothelioma Forecasted to 2023

- Global Market (2013-2015)

- Global Forecasted Market (2016-2023)

- Global Market by Geography

- Market of US (2013-2015)

- Forecasted Market of US (2016-2023)

- Market of Europe

- Market of Germany (2013-2015)

- Forecasted Market of Germany (2016-2023)

- Market of United Kingdom (2013-2015)

- Forecasted Market of United Kingdom (2016-2023)

- Market of France (2013-2015)

- Forecasted Market of France (2016-2023)

- Market of Italy (2013-2015)

- Forecasted Market of Italy (2016-2023)

- Market of Spain (2013-2015)

- Forecasted Market of Spain (2016-2023)

- Market of Japan (2013-2015)

- Forecasted Market of Japan (2016-2023)

- Market of ROW (2013-2015)

- Forecasted Market of ROW (2016-2023)

- Appendix

- Report Methodology

- Consulting Services

- Disclaimer

- Report Purchase Options

- About DelveInsight

List of Tables

- Table 1: Drug Description

- Table 2: Drug, Marketed Details United States (US)

- Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015

- Table 4: Drug, Patent Details for US

- Table 5: Malignant Mesothelioma Drug Sales (USD Millions)-2023

- Table 6: Global Epidemiology of Malignant Mesothelioma (2013-2023)

- Table 7: Malignant Mesothelioma Global Market (USD Millions), (2013-2015)

- Table 8: Malignant Mesothelioma Global Market (USD Millions), (2016-2023)

- Table 9: Malignant Mesothelioma US Market (USD Millions), (2013-2015)

- Table 10: Malignant Mesothelioma US Market (USD Millions), (2016-2023)

- Table 11: Malignant Mesothelioma Germany Market (USD Millions), (2013-2015)

- Table 12: Malignant Mesothelioma Germany Market (USD Millions), (2016-2023)

- Table 13: Malignant Mesothelioma United Kingdom Market (USD Millions), (2013-2015)

- Table 14: Malignant Mesothelioma United Kingdom Market (USD Millions), (2016-2023)

- Table 15: Malignant Mesothelioma France Market (USD Millions), (2013-2015)

- Table 16: Malignant Mesothelioma France Market (USD Millions), (2016-2023)

- Table 17: Malignant Mesothelioma Italy Market (USD Millions), (2013-2015)

- Table 18: Malignant Mesothelioma Italy Market (USD Millions), (2016-2023)

- Table 19: Malignant Mesothelioma Spain Market (USD Millions), (2013-2015)

- Table 20: Malignant Mesothelioma Spain Market (USD Millions), (2016-2023)

- Table 21: Malignant Mesothelioma Japan Market (USD Millions), (2013-2015)

- Table 22: Malignant Mesothelioma Japan Market (USD Millions), (2016-2023)

- Table 23: Malignant Mesothelioma ROW Market (USD Millions), (2013-2015)

- Table 24: Malignant Mesothelioma ROW Market (USD Millions), (2016-2023)

List of Figures

- Figure 1: Malignant Mesothelioma Drug Sales (USD Millions)-2023

- Figure 2: Global Epidemiology of Malignant Mesothelioma (2013-2023)

- Figure 3: Malignant Mesothelioma Global Market (USD Millions), (2013-2015)

- Figure 4: Malignant Mesothelioma Global Market (USD Millions), (2016-2023)

- Figure 5: Malignant Mesothelioma US Market (USD Millions), (2013-2015)

- Figure 6: Malignant Mesothelioma US Market (USD Millions), (2016-2023)

- Figure 7: Malignant Mesothelioma Germany Market (USD Millions), (2013-2015)

- Figure 8: Malignant Mesothelioma Germany Market (USD Millions), (2016-2023)

- Figure 9: Malignant Mesothelioma United Kingdom Market (USD Millions), (2013-2015)

- Figure 10: Malignant Mesothelioma United Kingdom Market (USD Millions), (2016-2023)

- Figure 11: Malignant Mesothelioma France Market (USD Millions), (2013-2015)

- Figure 12: Malignant Mesothelioma France Market (USD Millions), (2016-2023)

- Figure 13: Malignant Mesothelioma Italy Market (USD Millions), (2013-2015)

- Figure 14: Malignant Mesothelioma Italy Market (USD Millions), (2016-2023)

- Figure 15: Malignant Mesothelioma Spain Market (USD Millions), (2013-2015)

- Figure 16: Malignant Mesothelioma Spain Market (USD Millions), (2016-2023)

- Figure 17: Malignant Mesothelioma Japan Market (USD Millions), (2013-2015)

- Figure 18: Malignant Mesothelioma Japan Market (USD Millions), (2015-2023)

- Figure 19: Malignant Mesothelioma ROW Market (USD Millions), (2013-2015)

- Figure 20: Malignant Mesothelioma ROW Market (USD Millions), (2016-2023)

Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Note*: This report requires 5-10 business days to complete.
DelveInsight's Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Malignant Mesothelioma forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Malignant Mesothelioma till 2023.
Key Coverage and Benefits
The report will help in developing business strategies by understanding the trends shaping and driving the global Malignant Mesothelioma market.
Identifying patient populations in the global "Malignant Mesotheliomamarket to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Malignant Mesothelioma therapeutics in each of the markets covered.
To understand the future market competition in the global Malignant Mesothelioma therapeutics market and Insightful review of the key market drivers and barriers.
Scope
Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
It also provides Malignant Mesothelioma for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
  • United States Non-small Cell Lung Cancer Therapeutics Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Non-small Cell Lung Cancer Therapeutics Revenue, means the sales value of Non-small Cell Lung Cancer Therapeutics This report studies sales (consumption) of Non-small Cell Lung Cancer Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - GlaxoSmithKline - Menarini - Sanofi - ZIOPHARM Onco......
  • Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 477
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.The acute myeloid leukemia cells which resist treatment are referred to as refractory acute myeloid leukemia. Signs and symptoms includes pale skin, swollen gums, minor infections, such as perianal sores, loss of appetite and weight loss and aches or discomfo......
  • Small-Cell Lung Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 588
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It spreads much more quickly than non-small cell lung cancer. SCLC is the most aggressive form of lung cancer. It usually starts in the breathing tubes (bronchi) in the center of the chest. These tumors often spr......
  • Gallbladder Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 74
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer - Pipeline Review, H2 2016, provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape.Gallbladder cancer is a cancer that starts in the gallbladder. Symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark urine and weight loss. Risk factors include overweight, age, family history, gallstones, gender and choledochal cysts......
  • Vaginal Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 68
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Pipeline Review, H2 2016, provides an overview of the Vaginal Cancer (Oncology) pipeline landscape.Vaginal cancer is a rare cancer that occurs in vagina. Symptoms includes watery vaginal discharge, a lump or mass in vagina, painful urination, constipation and pelvic pain, vaginal bleeding. Risk factors include age, Smoking, HIV infection and vaginal intraepithelial neoplasia. Treatment include......
  • Epithelial Ovarian Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 507
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer - Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.Ovarian epithelial cancer is a disease in which malignant (cancer) cells form in the tissue covering the ovary. Early ovarian cancer may not cause any symptoms. When symptoms do appear, ovarian cancer is often advanced. Symptoms may include pain or swelling in the abdomen, p......
  • Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 463
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) pipeline landscape.Metastatic hormone refractory prostate cancer (mHRPC), also known as metastatic androgen independent prostate cancer or metastatic castrate-resis......
  • Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 108
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) (Oncology) pipeline landscape.Muscle-invasive disease is a type of bladder cancer which is much more likely to spread to other parts of the body Symptoms includes blood in the urine and pain when passing urine. Risk factors include use of tobacco, family history, exposure to arsen......
  • Follicular Lymphoma - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 540
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma - Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.Follicular lymphoma is a common type of non-Hodgkin Lymphoma (NHL). It is a slow-growing lymphoma that arises from B-cells, a type of white blood cell. It is also called an "indolent" or "low-grade" lymphoma for its slow nature. Follicular lymphoma mainly affects older adults. Enlargeme......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs